1.25 USD
0.000.00%
盘后 1.25 0.00%
2026-09-16
市值
$38.99M
市盈率
3.48
EPS
0.36
股息率
—
52 周区间
0.74 – 1.74
成交量
38.88K
Beta
0.05
目标价
3.50
52W 低 0.7452W 高 1.74
价格走势
公司简介
Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radiotherapeutic for patients with Relapsed/Refractory AML which is in to a Phase 2/3 Trial; and Iomab-ACT, to improve patient access to and outcomes with cellular therapies, such as CAR-T and gene therapies for non-malignant hematologic disorders such as sickle cell disease. It also develops ATNM-400, a antibody...